Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | AEMD Aethlon Medical, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $6.32 +0.2% | $15.86 +5.3% |
| StockIQ Score | 59C Moderate Risk: High | 38F Weak Risk: Medium |
| Technical | 61C+ | 21F |
| Fundamental | 46D+ | 35F |
| Growth | 68B- | 50C- |
| Fair Value | 55C | 38F |
| News | 100A+ | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Aethlon Medical (AEMD) outperforms Ascentage Pharma (AAPG) in nearly every category. Its investor and fundamental scores are significantly higher (46 vs. 37 and 46 vs. 35), and its growth score is also stronger (68 vs. 50). AAPG only leads in valuation (55 vs. 38), but AEMD’s overall rating is "Moderate" compared to AAPG’s "Weak." AEMD’s technical score (10) is notably lower, though.